Genome-wide cell-free DNA fragmentation in patients with cancerStephen Cristiano, Victor E. Velculescu, Mai‐Britt W. Ørntoft et al.|Nature|2019Cited by 1.5k
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung CancerValsamo Anagnostou, Victor E. Velculescu, Kellie N. Smith et al.|Cancer Discovery|2016Cited by 897
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomasYuchen Jiao, Laura D. Wood, Timothy M. Pawlik et al.|Nature Genetics|2013Cited by 709
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)Tricia R. Cottrell, Janis M. Taube, Elizabeth D. Thompson et al.|Annals of Oncology|2018Cited by 588
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung CancerMichael J. Topper, Stephen B. Baylin, Michelle Vaz et al.|Cell|2017Cited by 521